StonvexLoading…
StonvexStonvexStonvexCore line items from BB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-02-28 | Q4 2025 2025-11-30 | Q3 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $549.10M | $393.10M | $251.30M | $121.70M |
Operating Income | $48.30M | $25.40M | $13.50M | $2.00M |
Net Income | $53.20M | $28.90M | $15.20M | $1.90M |
EPS (Diluted) | $0.09 | $0.05 | $0.03 | $0.00 |
Total Assets | $1.25B | $1.22B | $1.18B | $1.21B |
Total Liabilities | $499.20M | $477.30M | $459.00M | $485.30M |
Cash & Equivalents | $274.70M | $270.30M | $276.40M | $276.00M |
Free Cash Flow OCF − CapEx | $46.50M | $1.60M | $-15.80M | $-18.90M |
Shares Outstanding | 587.43M | 590.39M | 590.36M | 594.53M |